Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Renehan

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Hematology/Oncology Clinics of North America|November 3, 2012
Current treatment of anal squamous cell carcinomaRob Glynne-Jones, Andrew Renehan
Urologic Oncology|May 3, 2008
Meta-analysis in medical research: potentials and limitationsMarcel Zwahlen, Andrew Renehan, Matthias Egger
Epidemiology (Cambridge, Mass.)|April 15, 2016
Collider Bias Is Only a Partial Explanation for the Obesity ParadoxMatthew Sperrin, Jane Candlish, Ellena Badrick, et al.
Annals of Surgical Oncology|April 17, 2019
Laparoscopic Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (L-CRS/HIPEC) for Perforated Low-Grade Appendiceal Mucinous Neoplasm (LAMN II)Ed Parkin, Chelliah Selvasekar, Malcolm Wilson, et al.
Cancer Epidemiology|January 18, 2016
Obesity and cancer: An update of the global impactMelina Arnold, Michael Leitzmann, Heinz Freisling, et al.
Surgical Endoscopy|September 25, 2013
Risk-reducing laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for low-grade appendiceal mucinous neoplasm: early outcomes and techniqueRebecca Fish, Chelliah Selvasekar, Peter Crichton, et al.
Lancet (London, England)|August 28, 2015
A presurgical window-of-opportunity study of metformin in obesity-driven endometrial cancerVanitha Sivalingam, Rhona McVey, Kyle Gilmour, et al.
Cancers|November 12, 2013
The Role of High Frequency Dynamic Threshold (HiDT) Serum Carcinoembryonic Antigen (CEA) Measurements in Colorectal Cancer Surveillance: A (Revisited) Hypothesis PaperIrene Grossmann, Charlotte Verberne, Geertruida De Bock, et al.
BJU International|March 5, 2014
Quantification of skeletal metastases in castrate-resistant prostate cancer predicts progression-free and overall survivalCampbell Tait, David Moore, Clare Hodgson, et al.
British Journal of Cancer|November 8, 2022
Age alone is not a barrier to efficacy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: analysis of 1138 patients from the UK and Ireland Colorectal Peritoneal Metastases RegistryMichael E Kelly, Niall J O'Sullivan, Jarlath C Bolger, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Hematology/Oncology Clinics of North America|November 3, 2012
Current treatment of anal squamous cell carcinomaRob Glynne-Jones, Andrew Renehan
Urologic Oncology|May 3, 2008
Meta-analysis in medical research: potentials and limitationsMarcel Zwahlen, Andrew Renehan, Matthias Egger
Epidemiology (Cambridge, Mass.)|April 15, 2016
Collider Bias Is Only a Partial Explanation for the Obesity ParadoxMatthew Sperrin, Jane Candlish, Ellena Badrick, et al.
Annals of Surgical Oncology|April 17, 2019
Laparoscopic Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (L-CRS/HIPEC) for Perforated Low-Grade Appendiceal Mucinous Neoplasm (LAMN II)Ed Parkin, Chelliah Selvasekar, Malcolm Wilson, et al.
Cancer Epidemiology|January 18, 2016
Obesity and cancer: An update of the global impactMelina Arnold, Michael Leitzmann, Heinz Freisling, et al.
Surgical Endoscopy|September 25, 2013
Risk-reducing laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for low-grade appendiceal mucinous neoplasm: early outcomes and techniqueRebecca Fish, Chelliah Selvasekar, Peter Crichton, et al.
Lancet (London, England)|August 28, 2015
A presurgical window-of-opportunity study of metformin in obesity-driven endometrial cancerVanitha Sivalingam, Rhona McVey, Kyle Gilmour, et al.
Cancers|November 12, 2013
The Role of High Frequency Dynamic Threshold (HiDT) Serum Carcinoembryonic Antigen (CEA) Measurements in Colorectal Cancer Surveillance: A (Revisited) Hypothesis PaperIrene Grossmann, Charlotte Verberne, Geertruida De Bock, et al.
BJU International|March 5, 2014
Quantification of skeletal metastases in castrate-resistant prostate cancer predicts progression-free and overall survivalCampbell Tait, David Moore, Clare Hodgson, et al.
British Journal of Cancer|November 8, 2022
Age alone is not a barrier to efficacy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: analysis of 1138 patients from the UK and Ireland Colorectal Peritoneal Metastases RegistryMichael E Kelly, Niall J O'Sullivan, Jarlath C Bolger, et al.
Pageof 2